checkAd
    Startseite > Aktien > Akero Therapeutics > Nachrichten
    Akero Therapeutics Aktie
    17,275
     
    EUR
    -3,68 %
    -0,660 EUR
    Letzter Kurs 29.05.24 Tradegate
    17,035
     
    EUR
    233 STK
    Geldkurs 11:00:55
    17,200
     
    EUR
    231 STK
    Briefkurs 11:00:55
    ISIN: US00973Y1082 · WKN: A2PLNP · SYM: 0K4 · USA

    Neueste Nachrichten

    Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
    29.05.24 · globenewswire · Akero Therapeutics
    AKRO EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AKRO
    22.05.24 · Business Wire (engl.) · Akero Therapeutics
    Kirby McInerney LLP Reminds Akero Therapeutics, Inc. (AKRO) Investors of Class Action Filing and Encourages Investors to Contact the Firm
    14.05.24 · Business Wire (engl.) · Akero Therapeutics
    AKRO Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Akero Therapeutics, Inc.
    11.05.24 · Business Wire (engl.) · Akero Therapeutics
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
    10.05.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    10.05.24 · globenewswire · Akero Therapeutics
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
    09.05.24 · Business Wire (engl.) · Akero Therapeutics
    Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
    08.05.24 · globenewswire · Akero Therapeutics
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
    07.05.24 · Business Wire (engl.) · Akero Therapeutics
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
    06.05.24 · Business Wire (engl.) · Akero Therapeutics
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
    06.05.24 · Business Wire (engl.) · Akero Therapeutics
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Akero Therapeutics, Inc. (AKRO) on Behalf of Investors
    03.05.24 · Business Wire (engl.) · Akero Therapeutics